此页面是自动翻译的,不保证翻译的准确性。请参阅 英文版 对于源文本。

更年期在温度调节中的作用

2026年10月1日 更新者:W. Larry Kenney、Penn State University

雌激素对绝经前和绝经后女性热应激的热调节反应的影响

The frequency and severity of heat waves has increased in the last decades. Older adults (over 65 years) have impaired responses to heat stress making them at increased risk for adverse events. Previous heat waves report that women over 65 experience worse health outcomes than any other age group and age matched men.

Aging and reproductive hormones, specifically estrogen, independently alter responses to heat stress. However, the combined effects of low estrogen following menopause and aging on the response to heat stress are unknown. In this study, the investigators will identify the role of estrogen in pre and post menopausal women on thermoregulatory responses to heat stress.

研究概览

详细说明

Premenopausal and postmenopausal women will be recruited and different interventions will be given to each group. To mimic a postmenopausal hormone profile, premenopausal women will be given a GnRH antagonist, which acutely reduces estrogen concentrations. This induces a temporary post-menopausal state without compounding aging effects. Postmenopausal women will be given a transdermal estradiol patch to acutely raise estrogen concentrations. Supplementing estrogen in postmenopausal women allows for the effect of menopausal low estrogen concentration to be removed from the physiological effects of aging.

Subjects sign an informed consent form and undergo a medical screening prior to participation. The screening includes a physical exam, anthropometry, chemical and lipid profiles.

Each subject will complete 6 (3 for each treatment) experimental trials. For each intervention, participants will complete one passive heating experiment first, followed by two active heating experiments.

研究类型

介入性

注册 (估计的)

24

阶段

  • 第四阶段

联系人和位置

本节提供了进行研究的人员的详细联系信息,以及有关进行该研究的地点的信息。

学习联系方式

  • 姓名:W. Larry Kenney, Ph.D.
  • 电话号码:814-863-1672
  • 邮箱:w7k@psu.edu

研究联系人备份

学习地点

    • Pennsylvania
      • University Park、Pennsylvania、美国、16802
        • 招聘中
        • Noll Laboratory
        • 接触:
          • W. Larry Kenney, Ph.D.
          • 电话号码:814-863-1672
          • 邮箱:w7k@psu.edu
        • 接触:

参与标准

研究人员寻找符合特定描述的人,称为资格标准。这些标准的一些例子是一个人的一般健康状况或先前的治疗。

资格标准

适合学习的年龄

42年 至 64年 (成人)

接受健康志愿者

是的

有资格学习的性别

女性

描述

Inclusion Criteria:

  • Women ages 42-64

Exclusion Criteria:

  • Chron's disease, diverticulitis, or similar gastrointestinal disease
  • Abnormal resting exercise electrocardiogram (ECG)
  • Tobacco use
  • High-risk determined by the Atherosclerotic Cardiovascular Disease (CVD) Risk Factor
  • Assessment
  • Using hormone therapy
  • Using hormonal contraceptives

学习计划

本节提供研究计划的详细信息,包括研究的设计方式和研究的衡量标准。

研究是如何设计的?

设计细节

  • 主要用途:基础科学
  • 分配:随机化
  • 介入模型:交叉作业
  • 屏蔽:双倍的

武器和干预

参与者组/臂
干预/治疗
实验性的:Premenopausal estrogen suppression

Participants take a cellulose placebo tablet for 4 days prior to baseline testing and continue until experimental visits are complete. Following completion of placebo testing, participants begin taking 400 mg/day Elagolix for 4 days prior to testing and continue until experimental visits are complete.

2 x 200 mg tablet

其他名称:
  • 奥里利萨

placebo tablet

实验性的:Postmenopausal estrogen supplementation

Participants wear a transdermal estradiol patch or placebo patch for 5 days prior to testing and continue until experimental visits are complete. After 48 hr washout, participants then wear the alternative treatment for 5 days prior to testing until experimental visits are complete.

0.05 mg/day patch

placebo patch

研究衡量的是什么?

主要结果指标

结果测量
措施说明
大体时间
Skin Blood Flow
大体时间:Monitored continuously during both 3 hour passive heating experiments (Visit 1 and Visit 3 approx 3 weeks)

Skin blood flow response to whole body heating is continuously monitored

Monitored continuously during both 3 hour passive heating experiments (Visit 1 and Visit 3 approx 3 weeks)
Local Sweat Rate
大体时间:Monitored continuously during both 3 hour passive heating experiments (Visit 1 and Visit 3 approx 3 weeks)

A small sweat capsule is placed on the forearm for the duration of whole body heating.

Monitored continuously during both 3 hour passive heating experiments (Visit 1 and Visit 3 approx 3 weeks)
Core Temperature
大体时间:Monitored continuously during all 3 hour experimental visits (6 total average of 3 weeks)

Changes in body temperature are measured through a telemetry pill swallowed before each experiment.

Monitored continuously during all 3 hour experimental visits (6 total average of 3 weeks)

次要结果测量

结果测量
措施说明
大体时间
Body Mass
大体时间:Baseline and following 3 hr experimental visit (6 total visits for study completion, an average of 3 weeks)

Body mass is measured on a scale.

Baseline and following 3 hr experimental visit (6 total visits for study completion, an average of 3 weeks)
Skin Temperature
大体时间:Calculated continuously for the duration of each 3 hr experimental visit (6 total visits for study completion, an average of 3 weeks)

Mean skin temperature is calculated from a weighted average of skin temperature from 4 different sites.

Calculated continuously for the duration of each 3 hr experimental visit (6 total visits for study completion, an average of 3 weeks)

合作者和调查者

在这里您可以找到参与这项研究的人员和组织。

调查人员

  • 首席研究员:W. Larry Kenney, Ph.D.、The Pennsylvania State University

研究记录日期

这些日期跟踪向 ClinicalTrials.gov 提交研究记录和摘要结果的进度。研究记录和报告的结果由国家医学图书馆 (NLM) 审查,以确保它们在发布到公共网站之前符合特定的质量控制标准。

研究主要日期

学习开始 (实际的)

2025年3月1日

初级完成 (估计的)

2026年12月1日

研究完成 (估计的)

2026年12月1日

研究注册日期

首次提交

2025年1月15日

首先提交符合 QC 标准的

2025年1月22日

首次发布 (实际的)

2025年1月29日

研究记录更新

最后更新发布 (实际的)

2026年10月2日

上次提交的符合 QC 标准的更新

2026年10月1日

最后验证

2026年10月1日

更多信息

与本研究相关的术语

其他相关的 MeSH 术语

其他研究编号

  • Study 25435

药物和器械信息、研究文件

研究美国 FDA 监管的药品

是的

研究美国 FDA 监管的设备产品

不

此信息直接从 clinicaltrials.gov 网站检索,没有任何更改。如果您有任何更改、删除或更新研究详细信息的请求,请联系 register@clinicaltrials.gov. clinicaltrials.gov 上实施更改,我们的网站上也会自动更新.

订阅